Osteoarthritis is considered to be the most common type of arthritis, affecting millions of people globally. It can be defined as a disorder that affects mostly the joints in a human body, and is caused by the inflammation, breakdown, and loss of cartilage in the joints of hand, knees, spine, and hip. This is also termed as degenerative arthritis. The major prevalence of this disorder is found in the geriatric population. Osteoarthritis on an average affects 10% of men and 12% of women that are aged above 60 years. It is a progressive disease that has no permanent cure, but its pain and swelling can be controlled with the help of pain killers that helps an individual to stay mobile and carry out regular activities.

Get Sample Copy of this Market Report Study @ https://bit.ly/2Kyu6Gj

Osteoarthritis normally begins after the age of 40 years, but can affect the younger people after traumatic injury. This is a chronic degenerative disorder that results in biochemical breakdown of the cartilages in the synovial joints. The wear and tear of the tissues over the time is one of the major cause of osteoarthritis. This disorder is majorly characterised by pain, stiffness, loss of flexibility, tenderness, and bone spurs. With no proper cure to this disorder the major painkillers are used for reducing the intensity of pain caused due to this disorder. Moreover, staying active by maintaining healthy weight by regular exercising and stretching may slow down the progression of this disorder and help in improving the pain and joint function. While, continuous increase in the number of phase III drugs such as Invossa, and Ampion would also influence the market in the near future.

Get full summary of this report @ https://bit.ly/2MtU93e

North America region is expected to dominate the global osteoarthritis market over the forecast period. North America holds major share owning to the continuous technological developments along with the strong presence of key players and the increasing R&D investments by these players and government. Additionally, increasing awareness for the use of biological therapies would also spur the market in North America. Moreover, geriatric population, and increased sedentary lifestyle preference would also support the market growth.

Do Inquiry Before Purchasing This Report @ https://bit.ly/2vRt17d